Cryoport provides leading edge cryogenic logistics solutions to the life sciences industry through the combination of purpose built proprietary packaging, advanced information technology and highly skilled logistics expertise which manages the entire cold chain logistics process. Cryoport Express liquid nitrogen dry vapor shippers are validated to maintain a constant C temperature for a plus day dynamic shipment duration, and its Cryoportal Logistics Management Platform assists in managing the entire logistics process, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport s total turnkey logistics solutions offer reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a green and environmentally friendly solution. Cryoport service options include recording the chain of condition and chain of custody for all shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes. For more information visit www.cryoport.com.
Quote | CryoPort Inc. (NASDAQ:CYRX)
Last: | $18.12 |
---|---|
Change Percent: | -1.04% |
Open: | $17.53 |
Close: | $18.12 |
High: | $18.165 |
Low: | $17.245 |
Volume: | 536,093 |
Last Trade Date Time: | 03/27/2024 03:00:00 am |
News | CryoPort Inc. (NASDAQ:CYRX)
2024-03-15 11:30:03 ET UBS analyst issues BUY recommendation for CYRX on March 15, 2024 10:00AM ET. The previous analyst recommendation was Buy. CYRX was trading at $15.21 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst re...
2024-03-14 11:56:14 ET Summary Cryoport, Inc.'s financial results for Q4 2023 fell short of expectations, with revenue declining and a significant net loss. Despite the potential for growth in the cell and gene therapy market, Cryoport's revenue growth is expected to be modest. ...
Message Board Posts | CryoPort Inc. (NASDAQ:CYRX)
Subject | By | Source | When |
---|---|---|---|
Boston IVF Agreement: Reproductive Material Shipments Across the U.S. | H2R | investorshub | 04/26/2023 5:20:40 PM |
Bjorn: Thanks for the link | Bjorn | investorshangout | 03/13/2023 3:36:02 PM |
whytestocks: $CYRX News Article - Cryoport Confirms No Financial Exposure to Silicon Valley Bank | whytestocks | investorshangout | 03/13/2023 3:30:57 PM |
whytestocks: $CYRX News Article - Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer P | whytestocks | investorshangout | 03/08/2023 7:15:48 PM |
That's a big if however if that | Jim l | investorshub | 02/26/2023 6:47:12 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-03-15 11:30:03 ET UBS analyst issues BUY recommendation for CYRX on March 15, 2024 10:00AM ET. The previous analyst recommendation was Buy. CYRX was trading at $15.21 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst re...
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Thursday. Shares of Build-A-Bear Workshop, Inc. (NYSE: BBW) rose ...
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire FY 2023 revenue of $233.3 million , in-line with guidance Year-over-year, Commercial Cell & Gene Therapy revenue rose 33%; BioStorage/BioServices revenue increased 45% Gl...